Showing 22,681 - 22,700 results of 32,141 for search '(( 50 ((a decrease) OR (teer decrease)) ) OR ( e ((nn decrease) OR (point decrease)) ))', query time: 0.93s Refine Results
  1. 22681

    Data_Sheet_1_Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study.pdf by M. Liset Rietman (6760496)

    Published 2019
    “…For the current analyses, we used data of 17 potentially relevant (bio)markers (e.g., body mass index (BMI), urea) from rounds 2 to 5 (1993–2012). …”
  2. 22682

    Behavior is best fit by models with independent attributes. by Aster Q. Perkins (22008260)

    Published 2025
    “…<b>(e)</b> Histograms of coefficient estimates across sessions for the mapping of each attribute, as in <b>c</b>. …”
  3. 22683

    DataSheet1_Pioglitazone treatment mitigates cardiovascular bioprosthetic degeneration in a chronic kidney disease model.PDF by Shintaro Katahira (19350541)

    Published 2024
    “…Aims<p>Chronic kidney disease (CKD) is a risk factor for the development of cardiovascular diseases, e.g., atherosclerosis and calcific aortic valve disease, leading inevitably to valve replacement surgery. …”
  4. 22684

    Impaired muscle function and integrity in SGCA- and SGCD-null mice. by S. Pasteuning-Vuhman (4348486)

    Published 2017
    “…<b>(g)</b> Force frequency relationship of the tibialis anterior muscle. Each data point represents the force measured at each frequency. …”
  5. 22685

    DataSheet_1_MAIT Cells Balance the Requirements for Immune Tolerance and Anti-Microbial Defense During Pregnancy.pdf by Johanna Raffetseder (658130)

    Published 2021
    “…We here characterized the presence and phenotype of Vα7.2<sup>+</sup>CD161<sup>+</sup> MAIT cells in blood and decidua (the uterine endometrium during pregnancy) from women pregnant in the 1<sup>st</sup> trimester, i.e., the time point when local immune tolerance develops. …”
  6. 22686
  7. 22687

    DataSheet_1_MAIT Balance the Requirements for Immune Tolerance and Anti-Microbial Defense During Pregnancy.pdf by Johanna Raffetseder (658130)

    Published 2021
    “…We here characterized the presence and phenotype of Vα7.2<sup>+</sup>CD161<sup>+</sup> MAIT cells in blood and decidua (the uterine endometrium during pregnancy) from women pregnant in the 1<sup>st</sup> trimester, i.e., the time point when local immune tolerance develops. …”
  8. 22688

    Sensitivity analysis to determine the effect of varying inhibitor adhesion kinetics upon treatment efficacy. by Paul A. Roberts (5171447)

    Published 2018
    “…Eqs <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006071#pcbi.1006071.e002" target="_blank">1</a>–<a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1006071#pcbi.1006071.e016" target="_blank">8</a> were solved using ode15s. inhibitors cm<sup>−3</sup> (the standard value). …”
  9. 22689

    Gemin2 is essential for viability and normal motor function. by Rebecca Borg (504387)

    Published 2013
    “…In a similar vein, the climbing success rate or the percentage of flies that reach beyond 8 cm within 10 seconds, was dramatically decreased at all the recorded time points. (<b>C</b>) Flies with muscle-specific Gemin2 depletion exhibit a progressive age-dependent decline in flight performance. …”
  10. 22690

    Data_Sheet_2_Trajectories of (Bio)markers During the Development of Cognitive Frailty in the Doetinchem Cohort Study.pdf by M. Liset Rietman (6760496)

    Published 2019
    “…For the current analyses, we used data of 17 potentially relevant (bio)markers (e.g., body mass index (BMI), urea) from rounds 2 to 5 (1993–2012). …”
  11. 22691

    A BRET-based Mpro biosensor containing a nanobody and tandem cleavage sites shows an increased cleavage rate by Geethakumari, Anupriya M

    Published 2025
    “…We envisage that the NB2E3 nanobody-2× Mpro biosensor engineered here will be useful in drug discovery and functional characterization of Mpro mutants in newly emerging SARS-CoV-2 variants as well as in detecting SARS-CoV-2 infection in a point-of-care testing (POCT) format.…”
    Get full text
    Get full text
    Get full text
    article
  12. 22692
  13. 22693

    Cytochalasin Delocalizes VASP from the Leading Edge, Changing the F-Actin Network and Cell Shape by Catherine I Lacayo (34086)

    Published 2007
    “…<div><p>(A) Time-lapse images show that overexpressed EGFP-VASP, which is enriched at the leading edge before addition of 1.0 μM cytochalasin D (time: 1:00, left panel), becomes weaker at the leading edge ∼2 min after cytochalasin treatment (time: 2:50, middle panel). …”
  14. 22694

    Knockdown of <i>CPSF6</i> leads to global shifts in PAS usage as well as major transcript and protein abundance changes. by Christoph Schmal (395936)

    Published 2023
    “…(<b>H</b>) Heatmap depicting NCOM values for the 50 isoforms with the largest shift among those transcripts that show a significant NCOM change upon <i>CPSF6</i> knockdown. …”
  15. 22695

    Suf/Spastizin controls cortical granule maturation. by Palsamy Kanagaraj (589557)

    Published 2014
    “…<p>(A) Electron micrographs of high-pressure frozen stage III oocytes. …”
  16. 22696
  17. 22697

    AE treatment induces autophagy, and inhibits angiogenesis and Hif-1α expression in xenografted tumors. by Alok De (446321)

    Published 2013
    “…<p>A. Photograph showing increased immunoexpression of beclin1 in xenografted tumors after being treated with AE. …”
  18. 22698
  19. 22699

    Bortezomib-induced NF-κB activation. by Li Jia (76051)

    Published 2012
    “…<p>Su-DHL8 cells were treated with 20 nM bortezomib with or without 50 µg/ml of CQ. (A and B) Effects of bortezomib or/and CQ on the levels of NF-κB proteins. …”
  20. 22700